India / Pharma Market to Grow by 12-14% Up to 2023
The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands…
Top Stories
Rankings / Top 10 Pharma Companies in Saudi Arabia
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD millions MAT Q1 2019. These top 10 corporations account for 50 percent of total sales in…
US Biotech Commercialisation Strategies / How Karyopharm & Ionis Are Approaching US vs ROW
With US still the reigning global champion in biotech innovation, the dynamic and vibrant biopharma ecosystem in…
Chinese Biotech Strategies / The Pros & Cons of In-Licensing
Since the Chinese biopharma boom started in the late-2000s, Chinese biotechs have seen in-licensing as a shortcut…
Download / Middle East & North Africa Pharma Data By Country Report 2020
HCLS Review Middle East & North Africa Data by Country is an extensive compilation of the latest…
Company Spotlight / How Chugai Became Japan's Top Pharma Company
In 2020, Chugai Pharmaceutical Co. became Japan’s biggest drug company, driven by strong performance in recent…
Data / Canada Pharma Snapshot 2020
Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics,…
In Conversation
Muhammad Ali Pate – Global Director for Health, Nutrition and Population; Director, Global Financing Facility for Women, Children & Adolescents, World Bank
Dr Muhammad Ali Pate, Global Director for Health, Nutrition and Population at the World Bank as well as Director of the Global Financing Facility for Women, Children and Adolescents, reflects on the impact of the current COVID-19 pandemic on the work that the global institution has been doing to promote the implementation of universal healthcare globally, the initiatives they are…
Latest Reports
Focus on Coronavirus
Pfizer’s Bourla & MSD’s Frazier: No Cutting…
Top global pharma executives involved in the development of COVID-19 vaccines…
Global Pharma Execs Hail ‘Unprecedented’ Speed &…
During the fourth International Federation of Pharmaceutical Manufacturers and…
Canada Pharma News Roundup September 2020
The latest news from Canadian pharma including deals for J&J’s and…
Spain Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19…
Read more: Coronavirus >>
Focus on Europe
Spain Pharma News Roundup September 2020
A roundup of the latest news from Spanish pharma, including J&J’s COVID-19…
Norway: Staking a Claim as a Pharma Research Hub?
Norway, more well-known internationally as an innovation hub for oil & gas…
Sandoz Bolsters its European Essential Medicine…
In the wake of the COVID-19 crisis and the subsequent strain placed on medicine…
Five Norwegian Medtechs to Watch
Norway, known more for its expertise in oil and gas and marine biology than in…
Read more: Europe >>
Focus on Japan
Korean Celltrion Makes First Big Global Move with…
Korean biosimilar firm Celltrion's USD 266 million acquisition of Japanese…
Precision Medicine in Asia: More Regional Cooperation Needed
With Asia covering 60 percent of the world’s population but accounting for…
Maintaining Open Innovation in Our ‘New Normal’ Through…
Toshio Fujimoto, MBA, MD of Japan’s Shonan Health Innovation Park explores new…
How Chugai Became Japan’s Top Pharma Company
In 2020, Chugai Pharmaceutical Co. became Japan’s biggest drug company, driven…
Read more: Japan >>
Focus on MEA
The Case for an Algerian FDA in the Wake of Unethical TV Ads
In the wake of a spate of television advertisements for dietary supplements…
Middle East & Africa Pharma News Roundup September 2020
A roundup of the latest news from pharma in the Middle East and Africa including…
Top 10 Pharma Companies in Saudi Arabia
The top 10 pharma companies in Saudi Arabia ranked by sales value in USD…
Algeria Pharma News Roundup July 2020
Below we present recent news from Algeria’s pharmaceutical industry, including…
Read more: MEA >>
Focus on China
China Pharma News Roundup September 2020
The latest from Chinese pharma, including a setback for CanSinoBIO’s Canadian…
Chinese Biotech Strategies: The Pros & Cons of…
Since the Chinese biopharma boom started in the late-2000s, Chinese biotechs…
Eli Lilly and Innovent take China Partnership Global
The partnership between global pharma giant Eli Lilly and Chinese biotech…
Biotech Spotlight: Alphamab Oncology, China
Founded in 2009 by CEO Dr XU Ting, Alphamab started its journey as a protein…
Read more: China >>
Focus on USA
Opinion: The Paradigm Shift Needed for Effective…
Holmusk’s Nawal Roy outlines why a cure for Alzheimer’s Disease is the…
US Biotech Commercialisation Strategies: How Karyopharm…
With US still the reigning global champion in biotech innovation, the dynamic…
Lundbeck US Head on COVID-19’s Dramatic Mental Health…
PharmaBoardroom recently spoke to CNS-focused Danish biopharma company…
J&J’s Momenta Deal A Further Sign of Big Pharma’s…
In the wake of Sanofi’s USD 3.7 billion tie-up for US biotech Principia,…